Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Invested Capital (2016 - 2025)

Historic Invested Capital for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $374.1 million.

  • CorMedix's Invested Capital rose 53722.53% to $374.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $374.1 million, marking a year-over-year increase of 53722.53%. This contributed to the annual value of $84.7 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CorMedix reported Invested Capital of $374.1 million as of Q3 2025, which was up 53722.53% from $220.6 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Invested Capital registered a high of $374.1 million during Q3 2025, and its lowest value of $46.2 million during Q2 2024.
  • In the last 5 years, CorMedix's Invested Capital had a median value of $62.3 million in 2021 and averaged $92.5 million.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 2943.39% in 2024, then soared by 53722.53% in 2025.
  • CorMedix's Invested Capital (Quarter) stood at $62.8 million in 2021, then dropped by 12.32% to $55.1 million in 2022, then surged by 51.11% to $83.2 million in 2023, then increased by 1.75% to $84.7 million in 2024, then surged by 341.94% to $374.1 million in 2025.
  • Its last three reported values are $374.1 million in Q3 2025, $220.6 million for Q2 2025, and $114.9 million during Q1 2025.